General Pharmaceuticals Market Research Reports & Industry Analysis
General Pharmaceuticals Industry Research & Market Reports
-
Cyclic Olefin Polymer Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2025-2034
... driven by rising demand for high-performance, transparent materials in the medical, pharmaceutical, and optical sectors. Cyclic olefin polymers (COPs) are gaining momentum due to their excellent optical clarity, moisture barrier properties, and biocompatibility, which make ... Read More
-
Thrombolytic Drugs Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2025-2034
... the increasing prevalence of cardiovascular and cerebrovascular diseases, rising demand for emergency care, and expanding access to advanced healthcare services. Thrombolytic drugs, also known as clot-busting agents, are used to dissolve dangerous clots in blood ... Read More
-
Marijuana Stores
... dominate the industry. COMPETITIVE LANDSCAPE Demand is driven by demographics, public awareness of the marijuana plant's medicinal properties, and the desire for natural health treatments. Following decades of prohibition in the US, marijuana has gained ... Read More
-
Thailand Medical Cannabis Market Report by Cultivated Species (Indica, Sativa, Hybrid), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC), and Others), Application Areas (Cancer, Arthritis, Migraine, Epilepsy, and Others), End-Use (Pharmaceuticals, Research and Development Centres, and Others), Route of Administration (Oral Solutions and Capsules, Vaporizers, Topicals, and Others) 2025-2033
... The market is propelled by the favorable government regulatory framework, widespread acceptance of the product, rapid growth of cultivation facilities and production capacity, increasing research and development (R&D) activities by key players, rising international investments ... Read More
-
Cannabis Edibles
... CAGR of 22.0% over the analysis period 2024-2030. Solid Edibles, one of the segments analyzed in the report, is expected to record a 22.2% CAGR and reach US$38.2 Billion by the end of the analysis ... Read More
-
Pharmaceutical Contract Manufacturing
... at a CAGR of 5.2% over the analysis period 2024-2030. Pharmaceutical, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$93.8 Billion by the end of the ... Read More
-
Lactoferrin
... 7.0% over the analysis period 2024-2030. Iron Absorption, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$161.1 Million by the end of the analysis period. Growth ... Read More
-
Cannabidiol
... 14.5% over the analysis period 2024-2030. Hemp, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$14.3 Billion by the end of the analysis period. Growth in ... Read More
-
Aluminum Stearates
... CAGR of 6.3% over the analysis period 2024-2030. Polymer & Rubber, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$348.9 Million by the end of the ... Read More
-
Sodium Alginate
... CAGR of 5.0% over the analysis period 2024-2030. Stabilizers, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$137.4 Million by the end of the analysis period. ... Read More
-
Natural Betaine
... CAGR of 5.8% over the analysis period 2024-2030. Food & Beverages, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$1.1 Billion by the end of the ... Read More
-
Coating Agents
... CAGR of 7.0% over the analysis period 2024-2030. The U.S. Market is Estimated at US$333.0 Million While China is Forecast to Grow at 10.5% CAGR The Coating Agents market in the U.S. is estimated at ... Read More
-
Glutamic Acid
... CAGR of 7.9% over the analysis period 2024-2030. Food & Beverage, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$14.6 Billion by the end of the ... Read More
-
Pharmerging
... 9.7% over the analysis period 2024-2030. Pharmaceutical, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth in ... Read More
-
D-Mannose
... 3.8% over the analysis period 2024-2030. Capsule, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$592.9 Million by the end of the analysis period. Growth in ... Read More
-
White Oil
... CAGR of 4.4% over the analysis period 2024-2030. Personal Care, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$720.4 Million by the end of the analysis ... Read More
-
Lyophilization Equipment and Services
... 2030, growing at a CAGR of 6.8% over the analysis period 2024-2030. Tray Lyophilizers, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$5.0 Billion by the ... Read More
-
Downstream Processing
... CAGR of 15.6% over the analysis period 2024-2030. Purification, one of the segments analyzed in the report, is expected to record a 16.3% CAGR and reach US$60.6 Billion by the end of the analysis period. ... Read More
-
Aseptic Processing
... CAGR of 3.5% over the analysis period 2024-2030. Plastics, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$59.0 Billion by the end of the analysis period. ... Read More
-
Proanthocyanidins
... 6.2% over the analysis period 2024-2030. Cranberry, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$177.2 Million by the end of the analysis period. Growth in ... Read More
-
Personalized Nutrition
... CAGR of 13.5% over the analysis period 2024-2030. Active Measurement, one of the segments analyzed in the report, is expected to record a 14.5% CAGR and reach US$27.5 Billion by the end of the analysis ... Read More
-
Mesifurane
... 6.4% over the analysis period 2024-2030. Food & Beverage, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$170.1 Million by the end of the analysis period. ... Read More
-
Glutamine
... 2.5% over the analysis period 2024-2030. Nutraceutical, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$106.0 Million by the end of the analysis period. Growth in ... Read More
-
Docosahexaenoic Acid (DHA)
... at a CAGR of 10.9% over the analysis period 2024-2030. Fish Oil DHA, one of the segments analyzed in the report, is expected to record a 12.2% CAGR and reach US$5.3 Billion by the end ... Read More
-
Vial Adaptors for Reconstitution Drug
... Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Polycarbonate, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$1.3 Billion by ... Read More
Research Assistance
